ClinicalTrials.Veeva

Menu

SV With TTPEE Measurement Predicts Upper Airway Patency in Prolonged Tracheostomy Patients

C

Capital Medical University

Status

Enrolling

Conditions

Tracheostomy

Treatments

Diagnostic Test: Bronchoscopy
Diagnostic Test: Speaking valve combined with airway pressure

Study type

Interventional

Funder types

Other

Identifiers

NCT07107243
2025-hxkfzx-dzx-001

Details and patient eligibility

About

The aim of this study is to evaluate the feasibility of predicting upper airway patency in patients with prolonged tracheostomy using a non-invasive method combining speaking valve (SV) and transtracheal end-expiratory pressure (TTPEE) through a multicenter study.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Weaned from ventilator more than 48 hours
  • No any organ failure
  • No sepsis
  • Stable heart rate and blood pressure
  • Lung infection under control
  • PCO2<60mmHg
  • Patient and family sign informed consent form

Exclusion criteria

  • Serious dysfunction of vital organs
  • Inability to tolerate cuff deflation
  • Laryngopharyngeal trauma
  • Known severe upper airway obstruction before referrer to our department
  • Endoscopy(bronchoscopy or laryngoscopy) has been performed and the condition of the upper airway has known

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

300 participants in 4 patient groups

True positive group
Experimental group
Description:
Upper airway non-patency is defined as positive; otherwise, it is negative. The true positive group is defined as those for whom both the results of the speaking valve (SV) with the transtracheal end-expiratory pressure (TTPEE) measurement protocol and the bronchoscopy are positive.
Treatment:
Diagnostic Test: Speaking valve combined with airway pressure
Diagnostic Test: Bronchoscopy
False positive group
Experimental group
Description:
Upper airway non-patency is defined as positive; otherwise, it is negative. The false positive group is defined as the group in which the result of the speaking valve (SV) with the transtracheal end-expiratory pressure (TTPEE) measurement protocol is positive, and the result of the bronchoscopy is negative.
Treatment:
Diagnostic Test: Speaking valve combined with airway pressure
Diagnostic Test: Bronchoscopy
True negative group
Experimental group
Description:
Upper airway non-patency is defined as positive; otherwise, it is negative. The true negative group is defined as those for whom both the results of the speaking valve (SV) with the transtracheal end-expiratory pressure (TTPEE) measurement protocol and the bronchoscopy are negative.
Treatment:
Diagnostic Test: Speaking valve combined with airway pressure
Diagnostic Test: Bronchoscopy
False negative group
Experimental group
Description:
Upper airway non-patency is defined as positive; otherwise, it is negative. The false negative group is defined as the group in which the result of the speaking valve (SV) with the transtracheal end-expiratory pressure (TTPEE) measurement protocol is negative, and the result of the bronchoscopy is positive.
Treatment:
Diagnostic Test: Speaking valve combined with airway pressure
Diagnostic Test: Bronchoscopy

Trial contacts and locations

5

Loading...

Central trial contact

Hongying Jiang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems